{"id":825209,"date":"2026-07-15T17:07:03","date_gmt":"2026-07-15T17:07:03","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=825209"},"modified":"2026-07-15T17:07:03","modified_gmt":"2026-07-15T17:07:03","slug":"leading-bay-area-ketamine-clinic-founder-explains-why-quality-treatment-should-extend-beyond-the-infusion","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/leading-bay-area-ketamine-clinic-founder-explains-why-quality-treatment-should-extend-beyond-the-infusion_825209.html","title":{"rendered":"Leading Bay Area Ketamine Clinic Founder Explains Why Quality Treatment Should Extend Beyond the Infusion"},"content":{"rendered":"
\"Leading<\/a><\/div>\n

MENLO PARK, CA –<\/strong> Recently featured in Psychedelic Business Journal’s report on ketamine-clinic saturation, Dr. Sara Herman, founder and medical director of Soft Reboot Wellness, is speaking out about what she sees as a critical gap in the growing ketamine industry: the difference between a fast infusion and genuine healing.<\/p>\n

“Ketamine treatment should not be organized around how quickly patients can be moved through a clinic,” says Dr. Herman, who leads Soft Reboot Wellness – a Bay Area Ketamine Therapy<\/a> practice built on trauma-informed, physician-guided care. “It should be organized around whether someone is an appropriate candidate, who is present with them during treatment, and what support they receive before and afterward.”<\/p>\n

A Harvard-trained, board-certified anesthesiologist and integrative medicine physician, Dr. Herman founded Soft Reboot Wellness in 2020 after years in high-acuity operating rooms, shifting her focus to helping patients heal from depression, anxiety, trauma, and nervous system dysregulation. As the founder of a Menlo Park, CA ketamine clinic<\/a>, she emphasizes that treatments are not designed as “one-and-done” interventions. New clients commit to at least two sessions to ensure proper preparation and integration, with most completing weekly two-hour-and-fifteen-minute sessions over four to twelve weeks, followed by gradually lengthened booster sessions to sustain progress and support neuroplastic healing.<\/p>\n

Dr. Herman also offers stellate ganglion block treatment in Bay Area<\/a> settings for patients with autonomic-dominant symptoms, underscoring that SGB is a legitimate, decades-old anesthesiology procedure — not a cure — that requires careful screening, individualized dosing, and safety standards.<\/p>\n

Unlike larger clinics, Soft Reboot Wellness focuses on root-cause healing rather than symptom management. Every protocol, including treatment-resistant depression therapy in Menlo Park, CA<\/a>, is individualized and grounded in neuroscience, psychopharmacology, and somatic awareness.<\/p>\n

“As interest in these therapies grows, it’s critical that we stay grounded in physiology, evidence, and patient-centered care while the research continues to evolve,” Dr. Herman adds.<\/p>\n

For more information, visit https:\/\/softrebootwellness.com\/<\/a> or call +1 (650) 419-3330.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Soft Reboot Wellness (Ketamine Therapy Clinic in Bay Area)<\/a>
Contact Person:<\/strong> Dr. Sara Herman
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 (650) 419-3330
Address:<\/strong>825 Oak Grove Ave # A101
City:<\/strong> Menlo Park
State:<\/strong> CA 94025
Country:<\/strong> United States
Website:<\/strong> https:\/\/softrebootwellness.com\/<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

MENLO PARK, CA – Recently featured in Psychedelic Business Journal’s report on ketamine-clinic saturation, Dr. Sara Herman, founder and medical director of Soft Reboot Wellness, is speaking out about what she sees as a critical gap in the growing ketamine … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,437,406,413,404],"tags":[],"class_list":["post-825209","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Lifestyle","category-Pharmaceuticals-Biotech","category-Services","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/825209","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=825209"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/825209\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=825209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=825209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=825209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}